Related Experiment Videos

High-dose chemotherapy for peripheral stem cell procurement in leukemia, lymphoma and multiple myeloma

H S Rugo¹, L E Damon, C A Ries

¹University of California, San Francisco.

Progress in Clinical and Biological Research

|January 1, 1994

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy on the I-SPY2 Trial.

Annals of surgical oncology·2026

Datopotamab deruxtecan versus chemotherapy in previously treated inoperable/metastatic hormone receptor-positive HER2-negative breast cancer: safety and patient-reported outcomes from the phase III TROPION-Breast01 study.

ESMO open·2026

Real-world postprogression outcomes after first-line treatment with ribociclib plus aromatase inhibitor versus aromatase inhibitor alone in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer in the United States of America.

ESMO open·2026

Genomic determinants of response to alpelisib plus fulvestrant in the SOLAR-1 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Sacituzumab govitecan in patients with metastatic breast cancer: pooled safety analysis of data from patients in North America, Europe, and Asia.

ESMO open·2026

TBCRC 035: randomized phase II pharmacodynamic study of standard and reduced-dose palbociclib with endocrine therapy in hormone receptor (HR)-positive previously treated metastatic breast cancer.

ESMO open·2026

See all related articles